Dr. Adey received his undergraduate degree in Biochemistry from the University of Texas where he worked in the lab of Dr. Andrew D. Ellington and served as the interim director of the UT Microarray Core Facility. He then completed his doctoral studies in Molecular and Cell Biology in the lab of Dr. Jay Shendure at the Genome Sciences Department at the University of Washington. During his graduate studies he pioneered several DNA sequencing technologies, including some that are routinely used around the globe. He also led work to sequence and characterize the genome of the HeLa cancer cell line where he utilized new technologies to provide novel insights into gene regulation in cancer. After completing his graduate studies he started his own independent group in the Department of Molecular and Medical Genetics at the Oregon Health and Science University, where he is now an Associate Professor. He is also a member of the Knight Cancer Institute, the Cancer Early Detection Advanced Research center, and the Knight Cardiovascular Institute. He was also the recipient of the 2018 American Society of Human Genetics Early Career Award. The Adey Lab is currently focused on the development and deployment of single-cell technologies to profile a variety of epigenetic properties with an emphasis on chromatin accessibility as well as the spatial tracking of cell positions. These technologies are being deployed to better understand fundamentals of gene regulation and their implications in neurodevelopment and cancer.